Zantac and ranitidine manufacturers face allegations that they ignored cancer risks associated with Zantac and ranitidine, and Zantac lawsuits are heating up. Thousands of claims alleging that Zantac causes cancer have been filed since an independent lab released an alarming report and the FDA issued its own Zantac warning. This litigation is relatively fast-moving and there have been many Zantac lawsuit updates as of late 2021. Stay tuned to this page for the latest in Zantac lawsuits. FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates. IMPORTANT: If you’ve been diagnosed with cancer after taking brand-name Zantac, you may be entitled to compensation. For a FREE, no-obligation consultation with an experienced Zantac lawyer, please call 1-800-525-7111. You won’t pay any attorney fees unless we win your case and recover compensation for you. ***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924). IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac.
Zantac Lawsuit Update - Late 2021
With thousands of lawsuits being filed, Zantac cases were consolidated into multi-district litigation (MDL) in the Southern District of Florida in February 2020. The first "bellwether" trial has been scheduled for October 10, 2022 in southern California. Bellwether trials are important in MDLs because they are used to weigh the evidence for and against claims. The outcome of the first Zantac bellwether trials in late 2022 will likely influence the defense's willingness to engage in settlement negotiations, as well as the size of any potential settlements.
Important Zantac Lawsuit Updates as of Late 2021:
- Zantac lawsuits have been consolidated into multi-district litigation (MDL) to streamline the legal process
- Judge Robin Rosenberg is overseeing the MDL in US District Court for the Southern District of Florida
- Thousands of lawsuits have been filed and legal analysts anticipate thousands more
- Defendants, including brand-name Zantac manufacturers GlaxoSmithKline (GSK) and Sanofi continue to deny any liability, negligence, and/or wrongdoing, and no settlements have been agreed to
- The first Zantac "bellwether" trial is scheduled to start October 10, 2022 in southern California
- There is still time to file a Zantac lawsuit but the clock is ticking
“What is the Zantac MDL and how does it work?”
An MDL is a legal mechanism for combining multiple, similar claims in order to expedite litigation. In the Zantac MDL, each plaintiff’s case remains separate, and plaintiffs are represented by their own attorneys. In the event of a global settlement, plaintiffs’ cases will be evaluated separately and awarded compensation, often based on a “tier” determined by his or her injuries and the strength of his or her claim. U.S. District Judge Robin Rosenberg is overseeing the MDL and has determined that the first trial will begin in October 2022. She has appointed 26 lawyers as co-lead counsel who will be charged with spearheading the litigation on behalf of plaintiffs in the MDL. IMPORTANT: For the latest court filings and trial updates, please visit the US District Court for the Southern District of Florida's Zantac MDL website. Even though the MDL is based in Florida, victims of cancer potentially caused by Zantac may be eligible to join the litigation from across the United States. FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates. To find out if you may qualify for a Zantac lawsuit, please call 1-800-525-7111 today and speak with an experienced injury lawyer handling Zantac claims.You may qualify for a Zantac lawsuit if you meet the following criteria:
- Used brand-name Zantac only
- Suffered from at least one of the following cancers:
- Bladder cancer
- Liver cancer
- Stomach cancer
- Esophageal cancer
- Pancreatic cancer
- Must have used brand-name Zantac after October 1984
- Must have used brand-name Zantac for a minimum of one year
- Must have used brand-name Zantac once per week for a minimum of six months
- Must have been diagnosed with a qualifying cancer within 20 years of last dose
- Must not have been a smoker in the past 20 years if diagnosed with lung cancer
- Must be 64 years of age or younger at the time of diagnosis if diagnosed with prostate cancer
Certain other criteria may apply. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney, please call 1-800-525-7111.
FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates. PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings. There is no obligation and there are no upfront costs or attorney fees unless you receive compensation. Please call 1-800-525-7111 today and let’s review your case.When Will Zantac Trials Start?
Zantac lawsuits
are in the very early stages of litigation, and the first Zantac trial is scheduled to begin October 10, 2022. These initial “bellwether” trials will offer a first glimpse into what kind of Zantac settlements plaintiffs may potentially expect.
Legal analysts anticipate that thousands more Zantac claims will have been filed by the time trials begin, and total compensation in Zantac cancer cases may reach into the billions of dollars. However, the outcome of Zantac trials is uncertain, defendants continue to deny liability, and there have been no Zantac settlements as of late 2021.
“I think Zantac caused my cancer. What should I do now?”
FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates. If you have been diagnosed with a qualifying cancer after taking brand-name Zantac, you may qualify for a Zantac lawsuit, and it is important that you contact an experienced Zantac cancer lawyer immediately. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney at Riddle & Brantley, please call 1-800-525-7111 or complete the fast and easy form below. There is no obligation and you won’t pay any attorney fees unless we win your case and you receive compensation. Call 1-800-525-7111 and let’s talk. IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.“What cancers does Zantac potentially cause?”
NDMA as found in Zantac has been linked to as many as 20 different types of cancer. Cancers potentially qualifying for a Zantac lawsuit include:- Stomach cancer
- Esophageal cancer
- Bladder cancer
- Intestinal cancer
- Pancreatic cancer
- Kidney cancer
- Liver cancer
- Prostate cancer
- Lung cancer (if you are a non-smoker)
What is Zantac?
Zantac is one of the world’s most commonly prescribed medication for treating heartburn, otherwise known as gastroesophageal reflux disease (GERD). It has been on the market in the United States since 1983 and millions have been exposed. Zantac is available in both prescription and over-the-counter forms, and a generic (ranitidine) is also available. Manufacturers of Zantac and generic ranitidine include:- Sanofi
- Boehringer
- Ingelheim
- GlaxoSmithKline (GSK)
- Amneal Pharmaceuticals
- Apotex Corp.
- Sandoz
- Defective design
- Failure to warn consumers
“Why are Zantac lawsuits being filed?”
In late 2019, an independent lab first discovered NDMA contamination in Zantac and generic ranitidine, findings that were later confirmed by the Food and Drug Administration (FDA). Zantac recalls were almost immediately issued, and popular pharmacies removed Zantac and ranitidine from their shelves. NDMA in Zantac represents a serious cancer risk. In fact, NDMA (N-Nitrosodimethylamine) is used in laboratories to cause cancer in rats and other animals. NDMA is classified as a “probable carcinogen,” meaning it may cause cancer in humans, by scientific organizations including the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the Environmental Protection Agency (EPA).Why Riddle & Brantley for Your Zantac Lawsuit?
If you’ve suffered from cancer potentially due to NDMA contamination in brand-name Zantac, you deserve justice — please call 1-800-525-7111 for a FREE consultation.
One of the award-winning injury attorneys at Riddle & Brantley can evaluate your claim, determine your eligibility for the Zantac MDL, and if you decide to hire us, fight tirelessly on your behalf for the compensation you deserve (see disclaimer below).
Attorney Gene Riddle and other lawyers with our firm have been recognized with membership in many prestigious organizations, (see disclaimer below), including:
- Multi-Million Dollar Advocates Forum
- Million Dollar Advocates Forum
- The National Trial Lawyers Top 100
- The National Association of Distinguished Counsel
- Super Lawyers
“This settlement changed me and my family’s lives.”-Linda B., Riddle & Brantley client Remember, the consultation is free and you won’t pay any attorney fess unless we win your case and you receive financial compensation. Call 1-800-525-7111 today and let’s review your claim. Justice Counts.
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case. *** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, The National Association of Distinguished Counsel, AV Preeminent by Martindale-Hubbell, the Litigator Award, and other memberships, awards, and accolades, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.